Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
A consortium of consumer groups filed suit against AstraZeneca last week, alleging misleading and deceptive advertising for its next- generation stomach medication, Nexium, which the suit claims is no more effective than its predecessor, Prilosec. The suit was filed in U.S. Superior Court in Los Angeles by the AFL-CIO, the Congress of California Seniors and the California Alliance of Retired Americans. The company spent $235 million on ads for Nexium last year, per Nielsen Monitor-Plus.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in